Choosing antibiotics for intra-abdominal infections: what do we mean by "high risk"?

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 2996818)

Published in Surg Infect (Larchmt) on February 01, 2009

Authors

Brian R Swenson1, Rosemarie Metzger, Traci L Hedrick, Shannon T McElearney, Heather L Evans, Robert L Smith, Tae W Chong, Kimberley A Popovsky, Timothy L Pruett, Robert G Sawyer

Author Affiliations

1: Department of Surgery, University of Virginia, Charlottesville, Virginia 22908-0709, USA.

Associated clinical trials:

Abdominal SepsiS Study: Epidemiology of Etiology and Outcome (AbSeS) | NCT02442596

Articles citing this

WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. World J Emerg Surg (2011) 1.29

A focus on intra-abdominal infections. World J Emerg Surg (2010) 1.10

Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs (2012) 1.04

Therapeutic management of peritonitis: a comprehensive guide for intensivists. Intensive Care Med (2016) 0.96

Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria. Eur J Med Res (2010) 0.91

Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med (2014) 0.88

Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options. BMC Infect Dis (2015) 0.84

Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection? Surg Infect (Larchmt) (2015) 0.81

A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis. PLoS One (2014) 0.80

Impact of Surgical Infection Society/Infectious Disease Society of America-recommended antibiotics on postoperative intra-abdominal abscess with image-guided percutaneous abscess drainage following gastrointestinal surgery. Surg Today (2014) 0.79

Bacterial species-specific hospital mortality rate for intra-abdominal infections. Surg Infect (Larchmt) (2014) 0.77

Evaluation of regional antibiograms to monitor antimicrobial resistance in Hampton Roads, Virginia. Ann Clin Microbiol Antimicrob (2015) 0.77

Clinical characteristics of ceftriaxone plus metronidazole in complicated intra-abdominal infection. Ann Surg Treat Res (2015) 0.75

Zinc Pyrithione Improves the Antibacterial Activity of Silver Sulfadiazine Ointment. mSphere (2016) 0.75

Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant Organisms. Open Forum Infect Dis (2016) 0.75

How to treat infections in a surgical intensive care unit. BMC Infect Dis (2014) 0.75

Articles cited by this

APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis (2003) 2.92

Candida as a risk factor for mortality in peritonitis. Crit Care Med (2006) 2.07

Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis (1996) 1.87

Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections. Ann Surg (2004) 1.57

The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt) (2002) 1.47

The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt) (2002) 1.23

Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg (1998) 1.07

Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains. Arch Surg (1999) 1.06

Comparison of fungal and nonfungal infections in a broad-based surgical patient population. Surg Infect (Larchmt) (2005) 0.96

Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection. Surg Infect (Larchmt) (2001) 0.90

In defense of routine antimicrobial susceptibility testing of operative site flora in patients with peritonitis. Clin Infect Dis (1997) 0.90

Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis. Clin Infect Dis (1997) 0.87

Articles by these authors

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59

Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis (2012) 5.24

Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med (2015) 5.21

Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02

Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. Am J Hum Genet (2005) 3.50

Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med (2005) 3.43

Central cannulation is safe in acute aortic dissection repair. J Thorac Cardiovasc Surg (2006) 2.98

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis (2003) 2.92

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67

Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64

Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42

Intravenous lidocaine is as effective as epidural bupivacaine in reducing ileus duration, hospital stay, and pain after open colon resection: a randomized clinical trial. Reg Anesth Pain Med (2010) 2.28

Wound infection after elective colorectal resection. Ann Surg (2004) 2.21

Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia. Crit Care Med (2012) 2.17

Bilateral adrenal hemorrhage: the unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia. Crit Care Med (2011) 2.06

Cost of Gram-negative resistance. Crit Care Med (2007) 2.05

Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg (2012) 2.00

Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90

Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol (2009) 1.89

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78

Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol (2012) 1.69

Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transpl (2007) 1.61

Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60

Contact isolation in surgical patients: a barrier to care? Surgery (2003) 1.60

Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) (2013) 1.60

Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen. Surg Infect (Larchmt) (2008) 1.58

Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58

Surgical site infection prevention: the importance of operative duration and blood transfusion--results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg (2008) 1.56

The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery (2013) 1.53

Idiopathic hydrocephalus in children and idiopathic intracranial hypertension in adults: two manifestations of the same pathophysiological process? J Neurosurg (2007) 1.52

Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg (2002) 1.50

Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl (2006) 1.49

Identification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections. Ann Surg (2010) 1.47

The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt) (2002) 1.47

Advanced recipient age (>60 years) alone should not be a contraindication to liver retransplantation. Transpl Int (2009) 1.43

The surgical care improvement project and prevention of post-operative infection, including surgical site infection. Surg Infect (Larchmt) (2011) 1.43

Risk of not being discharged home after isolated coronary artery bypass graft operations. Ann Thorac Surg (2013) 1.40

Preventing antimicrobial-resistant bacterial infections in surgical patients. Surg Infect (Larchmt) (2002) 1.39

Estradiol is associated with mortality in critically ill trauma and surgical patients. Crit Care Med (2008) 1.37

Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med (2003) 1.34

Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. Curr Drug Metab (2003) 1.25

Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int (2010) 1.25

Obesity and pulmonary complications in critically injured adults. Chest (2008) 1.24

The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt) (2002) 1.23

Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. J Thorac Cardiovasc Surg (2005) 1.22

Candida albicans and Saccharomyces cerevisiae expressing ALA1/ALS5 adhere to accessible threonine, serine, or alanine patches. Cell Commun Adhes (2002) 1.19

Efficacy of protocol implementation on incidence of wound infection in colorectal operations. J Am Coll Surg (2007) 1.19

Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials (2011) 1.16

High levels of endogenous estrogens are associated with death in the critically injured adult. J Trauma (2008) 1.16

Can we define the ideal duration of antibiotic therapy? Surg Infect (Larchmt) (2006) 1.15

Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections. Surg Infect (Larchmt) (2014) 1.15

Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology (2009) 1.15

An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13

Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. Transpl Int (2009) 1.12

Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis (2002) 1.11

Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg (2014) 1.10

Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09

The importance of isopropyl alcohol in skin preparation solutions. Infect Control Hosp Epidemiol (2011) 1.09

An evaluation of multidetector computed tomography in detecting pancreatic injury: results of a multicenter AAST study. J Trauma (2009) 1.08

Leclercia adecarboxylata bacteremia in a trauma patient: case report and review of the literature. Surg Infect (Larchmt) (2012) 1.08

Cardiac injury during resternotomy does not affect perioperative mortality. J Am Coll Surg (2008) 1.07

Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation (2005) 1.05

Part-time training in general surgery: results of a web-based survey. Arch Surg (2006) 1.05

Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02